[1]
2020. COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA. Voprosy onkologii. 66, 2 (Feb. 2020), 109–119. DOI:https://doi.org/10.37469/0507-3758-2020-66-2-109-119.